Total Payments
$727,742
2024 Payments
$178,460
Companies
23
Transactions
1,022
Medicare Patients
100
Medicare Billing
$15,979
Payment Breakdown by Category
Other$600,361 (82.5%)
Travel$55,397 (7.6%)
Consulting$39,446 (5.4%)
Food & Beverage$32,412 (4.5%)
Education$126.13 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $600,361 | 286 | 82.5% |
| Travel and Lodging | $55,397 | 148 | 7.6% |
| Consulting Fee | $39,446 | 11 | 5.4% |
| Food and Beverage | $32,412 | 571 | 4.5% |
| Education | $126.13 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $196,480 | 185 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $97,107 | 122 | $0 (2022) |
| ITI, Inc. | $89,940 | 95 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $61,624 | 69 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $59,358 | 72 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $41,088 | 47 | $0 (2024) |
| ABBVIE INC. | $40,544 | 108 | $0 (2024) |
| Allergan, Inc. | $36,111 | 118 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $32,522 | 35 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $29,672 | 58 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $178,460 | 215 | Teva Pharmaceuticals USA, Inc. ($41,123) |
| 2023 | $116,251 | 144 | ITI, Inc. ($32,593) |
| 2022 | $125,862 | 167 | Alkermes, Inc. ($52,539) |
| 2021 | $55,437 | 92 | Alkermes, Inc. ($25,804) |
| 2020 | $47,651 | 68 | Alkermes, Inc. ($23,739) |
| 2019 | $80,806 | 110 | Alkermes, Inc. ($46,271) |
| 2018 | $71,698 | 127 | Sunovion Pharmaceuticals Inc. ($59,109) |
| 2017 | $51,577 | 99 | Merck Sharp & Dohme Corporation ($29,672) |
All Payment Transactions
1,022 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $86.94 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $103.55 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,220.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $6.19 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/16/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/16/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $773.66 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/16/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $102.79 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $90.88 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $73.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $996.69 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $93.75 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,840.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,840.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $95.53 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,300.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/03/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/03/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $99.65 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $965.53 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $255.50 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $40.26 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,220.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $84.23 | General |
| Category: Psychiatry/Psychology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 35 | 80 | $20,511 | $5,865 |
| 2021 | 2 | 31 | 71 | $14,926 | $5,491 |
| 2020 | 2 | 34 | 72 | $16,398 | $4,623 |
Total Patients
100
Total Services
223
Medicare Billing
$15,979
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 45 | $13,325 | $3,873 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 35 | $7,186 | $1,992 | 27.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 30 | $7,710 | $3,013 | 39.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 41 | $7,216 | $2,477 | 34.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 46 | $11,822 | $3,198 | 27.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 26 | $4,576 | $1,425 | 31.1% |
About Dr. James Greer, MD
Dr. James Greer, MD is a Psychiatry healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548268303.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Greer, MD has received a total of $727,742 in payments from pharmaceutical and medical device companies, with $178,460 received in 2024. These payments were reported across 1,022 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($600,361).
As a Medicare-enrolled provider, Greer has provided services to 100 Medicare beneficiaries, totaling 223 services with total Medicare billing of $15,979. Data is available for 3 years (2020–2022), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location Providence, RI
- Active Since 07/14/2005
- Last Updated 10/18/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1548268303
Products in Payments
- CAPLYTA (Drug) $107,122
- LYBALVI (Drug) $101,091
- LATUDA (Drug) $97,107
- ARISTADA (Drug) $95,292
- VRAYLAR (Drug) $76,655
- INGREZZA (Drug) $61,624
- UZEDY (Drug) $59,323
- FANAPT (Drug) $41,088
- BELSOMRA (Drug) $29,672
- COBENFY (Drug) $16,198
- QUVIVIQ (Drug) $9,792
- QELBREE (Drug) $6,095
- REXULTI (Drug) $4,159
- Auvelity (Drug) $426.87
- MYDAYIS (Drug) $291.72
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $243.21
- Azstarys (Drug) $209.42
- JORNAY PM (Drug) $153.91
- SUBLOCADE (Drug) $139.72
- ABILIFY MAINTENA (Drug) $136.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Providence
Linda Carpenter, Md, MD
Psychiatry — Payments: $43,650
Psychiatry $43,650
Brian Ackerman
Psychiatry — Payments: $9,878
Psychiatry $9,878
Steven Rasmussen, Md, MD
Psychiatry — Payments: $6,302
Psychiatry $6,302
Kazi Salahuddin, Md, MD
Psychiatry — Payments: $4,840
Psychiatry $4,840
Katharine Phillips, Md, MD
Psychiatry — Payments: $4,723
Psychiatry $4,723
Dr. Timothy Mariano, M.d., Ph.d, M.D., PH.D
Psychiatry — Payments: $4,409
Psychiatry $4,409